SequelSEC

EyePoint, Inc. EYPT

Laboratory Analytical Instruments · CIK 0001314102 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$507.00K
Fiscal year ended 2026-06-30
Operating income
-$97.38M
Fiscal year ended 2026-06-30
Free cash flow
-$63.55M
Fiscal year ended 2026-06-30

EyePoint, Inc. (EYPT) reported revenue of $507.00K and net income of -$94.47M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from EyePoint, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Laboratory Analytical Instruments.

Income

EyePoint, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Revenue$507.00K$696.00K$620.00K$966.00K$5.33M$24.45M$11.59M$10.52M$9.48M$11.68M
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$736.00K$1.40M$759.00K
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating income-$97.38M-$87.23M-$70.34M-$62.02M-$62.23M-$48.84M-$45.24M-$32.75M-$34.55M-$33.32M
Net income-$94.47M-$84.83M-$67.61M-$59.73M-$59.43M-$45.20M-$41.40M-$29.36M-$30.83M-$29.28M
Research & development$83.61M$72.15M$59.21M$47.75M$55.50M$58.57M$43.37M$29.54M$29.82M$30.14M
Weighted-average diluted sharesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableshares 52.91M
Pretax income-$94.47MUnavailable-$67.42M-$59.73M-$59.33MUnavailable-$41.31M-$29.36M-$30.83MUnavailable
Income tax expense$0-$50.00K$186.00K$0$93.00K$0$90.00K$0$0Unavailable
Diluted EPS$-1.09$-0.99Unavailable$-0.85$-0.85$-0.65Unavailable$-0.54$-0.58$-0.55
Selling, general & administrative$14.27M$15.25M$11.38M$14.52M$11.90M$13.91M$12.64M$12.99M$12.80M$14.11M
General & administrative$14.24M$15.24M$11.38M$14.49M$11.86M$13.88M$12.59M$12.97M$12.75M$14.10M
Selling & marketing$31.00K$3.00K-$6.00K$26.00K$35.00K$35.00K$51.00K$24.00K$50.00K$6.00K

Balance

EyePoint, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Cash & equivalents$110.46M$77.71M$101.82M$74.58M$71.14M$85.16M$99.70M$79.83M$90.77M$271.01M
Total assets$228.19M$288.22M$364.00M$251.70M$301.15M$362.56M$418.46M$300.92M$324.25M$329.25M
Current assets$188.82M$249.50M$328.66M$216.11M$265.25M$326.98M$383.31M$268.55M$294.93M$317.71M
Total liabilities$61.78M$57.74M$57.88M$51.51M$55.14M$64.17M$81.96M$82.18M$95.94M$79.31M
Current liabilities$41.94M$37.46M$37.02M$30.09M$33.18M$41.68M$49.05M$48.79M$62.10M$62.58M
Total equity incl. NCI$166.41M$230.47M$306.11M$200.18M$246.01M$298.40M$336.50M$218.73M$228.30M$249.93M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$1.88M$1.25M$1.81M$2.11M$2.68M$2.13M$2.30M$2.81M$3.67M$4.26M
Accounts receivableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$17.27M$18.81M$10.49M$10.08M$19.68M$16.42M$11.72M$7.34M$14.30M$7.08M

Cash flow

EyePoint, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Operating cash flow-$62.35M-$80.55M-$65.05M-$59.35M-$62.59M-$53.12M-$35.85M-$39.03M-$20.18M-$31.17M
Capital expenditures$1.20M$997.00K$986.00K$798.00K$1.22M$276.00K$384.00K$1.57M$900.00K$1.19M
Investing cash flow$75.10M$59.05M-$74.67M$55.38M$48.34M$39.52M-$95.96M$16.20M-$160.40M$20.81M
Financing cash flow$19.99M-$2.61M$166.96M$7.40M$238.00K-$951.00K$151.68M$11.89M$329.00K$115.00K
Net change in cash$32.75M-$24.11M$27.24M$3.43M-$14.02M-$14.55M$19.87M-$10.94M-$180.24M-$10.25M
Stock-based compensation$10.40M$11.64M$6.75M$6.43M$6.88M$7.82M$7.90M$7.45M$8.70M$12.70M
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$690.00K$636.00K$698.00K$576.00K$538.00K$497.00K$467.00K$408.00K$362.00K$303.00K

Derived

EyePoint, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Free cash flow-$63.55M-$81.55M-$66.03M-$60.15M-$63.81M-$53.40M-$36.23M-$40.60M-$21.08M-$32.36M
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating margin-19207.1%-12532.5%-11346.0%-6420.8%-1166.8%-199.7%-390.4%-311.2%-364.5%-285.2%
FCF margin-12534.1%-11716.4%-10650.5%-6226.9%-1196.5%-218.4%-312.7%-385.8%-222.4%-277.0%
SBC / revenue2050.9%1672.1%1088.5%665.4%128.9%32.0%68.2%70.8%91.7%108.7%
Current ratio4.50x6.66x8.88x7.18x8.00x7.85x7.81x5.50x4.75x5.08x
Revenue YoY growth-90.5%-97.2%-94.6%-90.8%-43.7%109.3%-17.4%-30.8%4.1%52.1%
Net margin-18633.1%-12188.5%-10904.7%-6183.4%-1114.3%-184.8%-357.3%-279.0%-325.3%-250.6%
R&D / revenue16491.9%10366.1%9550.6%4943.5%1040.7%239.5%374.3%280.7%314.7%258.0%
CapEx / revenue236.7%143.2%159.0%82.6%22.9%1.1%3.3%15.0%9.5%10.2%
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open EYPT in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-05View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-03-05View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-08View SEC filing

Companies in the same industry

Reconciliation checks needing review

3 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

gross profit bridgeinconsistent2024-09-30

Withheld: gross profit could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2024-06-30

Withheld: gross profit could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2024-03-31

Withheld: gross profit could not be reconciled with the rest of this filer’s statement.